astronomy

Laurent Levy

Laurent Levy is a astronomy topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Laurent Levy rather than just read about it. In short: Laurent Levy (born 1971) is a French physical chemist, inventor, and pioneer of nanotechnology and nanomedicine. He is the co-founder of the global biotechnology company Nanobiotix, and has served as chief executive officer (CEO) since its inception in March 2003.

Key takeaways

Laurent Levy belongs to astronomy; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Laurent Levy to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Laurent Levy from memory before moving on to harder problems.

Reference excerpt

Laurent Levy (born 1971) is a French physical chemist, inventor, and pioneer of nanotechnology and nanomedicine. He is the co-founder of the global biotechnology company Nanobiotix, and has served as chief executive officer (CEO) since its inception in March 2003. He also authored more than 35 international scientific publications and has applied for several patents.

Early life and education Laurent Levy was born on the outskirts of northern-east Paris, France, in Montreuil. After high school, Laurent went on to study biology at Pierre and Marie Curie University (Paris VI). He changed his area of study to biophysics then to physics and chemistry after two years, graduating with his bachelor's degree in 1994. He then earned his master's degree (DEA) in physics of condensed matter from UPVI-ESPCI. Laurent attended Paris VI and the CEA for doctoral studies in physical chemistry, specializing in nanomaterials. His doctoral thesis centered on quantum confinement as it relates to magnetic semiconductors. Following the receipt of his doctorate, Levy completed a postdoctoral fellowship with Prof. Paras N. Prasad at the Institute for Lasers, Photonics, and Biophotonics at SUNY Buffalo in the United States.

Work In 2003, Levy founded Nanobiotix to create a medical treatment using the techniques he developed at SUNY Buffalo. Nanobiotix would build on his work to develop what is now known as NBTXR3, a first-in-class “radioenhancer” designed to significantly increase the efficacy of radiation therapy without increasing negative side effects associated with radiation. In 2011, Nanobiotix treated its first patient using NBTXR3. In 2018 the results of a phase III clinical trial established that this new type of product could work in humans. In 2019 the company received approval to sell NBTXR3 in Europe under the brand name Hensify® for the treatment of soft tissue sarcomas of the extremities and trunk wall. In 2015 Levy joined the board of biotech startup Valbiotis, the first company to register a nutraceutical based on clinical findings. The company develops nutraceutical products for the prevention of diabetes in pre-diabetics. Levy helped take Valbiotis public in 2018. In 2019, Levy co-founded the biotechnology company Curadigm as a spin-off from Nanobiotix. Curadigm's lead technology is a nanoprimer that affects liver function, reducing its ability to filter out drugs, making drug delivery more efficacious.

European nanomedicine advocacy As Nanobiotix grew, Levy became increasingly frustrated at the struggles nanomedicine companies faced in gaining visibility and support in the European Union. To advocate for nanomedical development, Levy joined the European Technology Platform Nanomedicine (ETPN) in 2012 and was elected vice president. Levy is a founding member of the ETPN Translation Advisory Board, which has supported 109 European biotech entrepreneurs in launching their companies. Levy also helped to establish the ETPN's Nanomedicine Translation Hub, which advises SMEs, Startups, Academics and Inventors on how to bring their nanomedicine projects to the market.

Awards and recognition 2019 Prix Galien 2018 CPhI Pharma Award - Excellence in Pharma: CEO of the year Laurent Levy CPhI Pharma Award - Pharma Company of the year : Nanobiotix European Business Award 2018 : The award for Innovation 2016 European Mediscience Award: Best technology Award 2015 Prix de la relation actionnaires 2013 University of Buffalo Young Entrepreneurs Prize : Laurent Levy 2006 Paris Bio Prize 2003 Inventor of the year: Niagara frontier intellectual property law association

External links Tedx Talk

Patents NANOBIOTIX CORE TECHNOLOGY ACTIVATABLE PARTICLES NANOPARTICLE DELIVERY SYSTEMS, PREPARATION AND USES THEREOF NANOPARTICLES COMPRISING METALLIC AND HAFNIUM OXIDE MATERIALS, PREPARATION AND USES THEREOF INORGANIC NANOPARTICLES COMPOSITIONS IN COMBINATION WITH IONIZING RADIATIONS FOR TREATING CANCER COMPOSITIONS AND METHODS FOR USE IN MEDICAL DIAGNOSIS COMPOSITIONS AND METHODS FOR USE IN ONCOLOGY PHARMACEUTICAL COMPOSITION COMPRISING NANOPARTICLES, PREPARATION AND USES THEREOF NANOPARTICLES FOR USE AS A THERAPEUTIC VACCINE METALLIC NANOPARTICLES, PREPARATION AND USES THEREOF WO/2014/191569: PHARMACEUTICAL COMPOSITION, PREPARATION AND USES THEREOF PHARMACEUTICAL COMPOSITION COMBINING AT LEAST TWO DISTINCT NANOPARTICLES AND A PHARMACEUTICAL COMPOUND, PREPARATION AND USES THEREOF NANOPARTICLES FOR USE FOR TREATING A NEURONAL DISORDER NANOPARTICLES FOR USE FOR ENHANCING BRAIN PERFORMANCES OR FOR TREATING STRESS COATED NANOPARTICLES FOR USE FOR MODULATING ELECTRICAL POLARIZATION OF NEURONS NANOPARTICLES FOR USE FOR TREATING A NEURONAL DISORDER

Publications Levy, Laurent; Sahoo, Yudhisthira; Kim, Kyoung-Soo; Bergey, Earl J.; Prasad, Paras N. (2002). "Nanochemistry: Synthesis and Characterization of Multifunctional Nanoclinics for Biological Applications". Chemistry of Materials. 14 (9). American Chemical Society (ACS): 3715–3721. doi:10.1021/cm0203013. ISSN 0897-4756. Maggiorella, Laurence; Barouch, Gilles; Devaux, Corinne; Pottier, Agnès; Deutsch, Eric; Bourhis, Jean; Borghi, Elsa; Levy, Laurent (2012). "Nanoscale radiotherapy with hafnium oxide nanoparticles". Future Oncology. 8 (9). Future Medicine Ltd: 1167–1181. doi:10.2217/fon.12.96. ISSN 1479-6694. PMID 23030491. Bergey, Earl J.; Levy, Laurent; Wang, Xiaopeng; Krebs, Linda J.; Lal, Manjari; Kim, Kyoung-Soo; Pakatchi, Shadi; Liebow, Charles; Prasad, Paras N. (2002). "DC Magnetic Field Induced Magnetocytolysis of Cancer Cells Targeted by LH-RH Magnetic Nanoparticles in vitro". Biomedical Microdevices. 4 (4). Springer Science and Business Media LLC: 293–299. doi:10.1023/a:1020906307053. ISSN 1387-2176. S2CID 134380514.

References

Illustrations

Worked examples

Example 1 — a first encounter with Laurent Levy

Start with the simplest possible case. Write down what Laurent Levy claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In astronomy, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Laurent Levy before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Laurent Levy ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Laurent Levy

In research: Laurent Levy appears in astronomy research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Laurent Levy in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Laurent Levy is common in secondary-school and first-year university syllabi. It links to neighbouring topics 1971 births, French chief executives, French chief executives in the health care industry, so understanding it makes those chapters shorter.
In everyday life: Look for Laurent Levy outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Laurent Levy” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Laurent Levy in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Laurent Levy means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Laurent Levy out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Laurent Levy in simple terms?

Why does Laurent Levy matter?

Because it connects several astronomy ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Laurent Levy?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Laurent Levy.